Literature DB >> 19356591

Revealing a concealed intermediate that forms after the rate-limiting step of refolding of the SH3 domain of PI3 kinase.

Ajazul Hamid Wani1, Jayant B Udgaonkar.   

Abstract

Kinetic and equilibrium studies of the folding and unfolding of the SH3 domain of the PI3 kinase, have been used to identify a folding intermediate that forms after the rate-limiting step on the folding pathway. Folding and unfolding, in urea as well as in guanidine hydrochloride (GdnHCl), were studied by monitoring changes in the intrinsic fluorescence or in the far-UV circular dichroism (CD) of the protein. The two probes yield non-coincident equilibrium transitions for unfolding in urea, indicating that an intermediate, I, exists in equilibrium with native (N) and unfolded (U) protein, during unfolding. Hence, the equilibrium unfolding data were analyzed according to a three-state N <--> I <--> U mechanism. An intermediate is observed also in kinetic unfolding studies, and its presence leads to the unfolding reaction in urea as well as in GdnHCl, occurring in two steps. The fast step is complete within the initial 11 ms of unfolding and manifests itself in a burst phase change in fluorescence. At high concentrations of GdnHCl, the entire change in fluorescence during unfolding occurs during the 11 ms burst phase. CD measurements indicate, however, that I retains N-like secondary structure. An analysis of the kinetic and thermodynamic data, according to a minimal three-state N <--> I <--> U mechanism, positions I after the rate-limiting transition state, TS1, of folding, on the reaction coordinate of folding in GdnHCl. Hence, I is not revealed when folding is commenced from U, regardless of the nature of the probe used to follow the folding reaction. Interrupted unfolding experiments, in which the protein is unfolded transiently in GdnHCl for various lengths of time before being refolded, showed that I refolds to N much faster than does U, confirms the analysis of the direct folding and unfolding experiments, that I is formed after the rate-limiting step of refolding in GdnHCl.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356591     DOI: 10.1016/j.jmb.2009.01.060

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Characterization of deamidation of barstar using electrospray ionization quadrupole time-of-flight mass spectrometry, which stabilizes an equilibrium unfolding intermediate.

Authors:  Santosh Kumar Jha; Putchen Dakshinamoorthy Deepalakshmi; Jayant B Udgaonkar
Journal:  Protein Sci       Date:  2012-03-16       Impact factor: 6.725

2.  Unfolding of a small protein proceeds via dry and wet globules and a solvated transition state.

Authors:  Saswata Sankar Sarkar; Jayant B Udgaonkar; Guruswamy Krishnamoorthy
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

3.  Spontaneous refolding of the large multidomain protein malate synthase G proceeds through misfolding traps.

Authors:  Vipul Kumar; Tapan K Chaudhuri
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

Review 4.  How cooperative are protein folding and unfolding transitions?

Authors:  Pooja Malhotra; Jayant B Udgaonkar
Journal:  Protein Sci       Date:  2016-09-13       Impact factor: 6.725

5.  Binding-induced folding under unfolding conditions: Switching between induced fit and conformational selection mechanisms.

Authors:  Sreemantee Sen; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2019-10-03       Impact factor: 5.157

6.  Native state dynamics drive the unfolding of the SH3 domain of PI3 kinase at high denaturant concentration.

Authors:  Ajazul Hamid Wani; Jayant B Udgaonkar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

7.  The effect of C-terminal helix on the stability of FF domain studied by molecular dynamics simulation.

Authors:  Liling Zhao; Zanxia Cao; Jihua Wang
Journal:  Int J Mol Sci       Date:  2012-02-07       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.